S. Durham

发表

Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper

B. Yawn, W. Busse, H. Schünemann, 2010 .

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA 2 LEN paper

Bateman, B. Yawn, W. Busse, 2010 .

EAACI guidelines on allergen immunotherapy: Executive statement

A. Sheikh, R. Van Ree, C. Bachert, 2018, Allergy.

Practical guide to skin prick tests in allergy to aeroallergens

J. Bousquet, T. Zuberbier, C. Bachert, 2012, Allergy.

Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics.

S. Durham, M. Humbert, J. Tavernier, 1997, American journal of respiratory and critical care medicine.

Allergen immunotherapy: does it work and, if so, how and for how long?

S. Durham, E. Varga, Q. Hamid, 2000, Thorax.

Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

T. Zuberbier, S. Durham, L. Klimek, 2021, Allergy.

Long-term clinical and immunological effects of allergen immunotherapy

S. Durham, A. Eifan, M. Shamji, 2011, Current opinion in allergy and clinical immunology.

Characteristics of patients with seasonal allergic rhinitis and concomitant asthma

W. Busse, A. Harris, H. Boushey, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

G. Viegi, A. Chuchalin, J. Li, 2008, Allergy.

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update

B. Yawn, L. Boulet, J. Bousquet, 2008 .

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

S. Durham, R. Dahl, B. Riis, 2008, The Journal of allergy and clinical immunology.

Practice and safety of allergen‐specific immunotherapy for allergic rhinitis in the UK national health service: A report of “real world” clinical practice

S. Durham, P. Huber, S. Nasser, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007)

S. Durham, G. Scadding, G. Roberts, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Systematic assessment of difficult-to-treat asthma

S. Durham, K. Chung, P. Barnes, 2003, European Respiratory Journal.

EAACI Allergen Immunotherapy User's Guide

S. Durham, A. Muraro, C. Akdis, 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Allergen Immunotherapy in Children User’s Guide

S. Durham, A. Muraro, C. Akdis, 2020 .

Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial

S. Durham, V. Lund, C. Hopkins, 2019, Trials.

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.

J. Bousquet, C. Bachert, G. Canonica, 2004, The Journal of allergy and clinical immunology.

Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.

S. Durham, A. Kay, Q. Hamid, 1993, American journal of respiratory cell and molecular biology.

The clinical safety of H1‐receptor antagonists: An EAACI position paper *

J. Bousquet, C. Bachert, G. Canonica, 1996, Allergy.

Increased interleukin-10 messenger RNA expression in atopic allergy and asthma.

S. Durham, A. Kay, Q. Hamid, 1996, American journal of respiratory cell and molecular biology.

Effects of a reversible β‐tryptase and trypsin inhibitor (RWJ‐58643) on nasal allergic responses

S. Durham, P. Barnes, E. Erin, 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Aluminium hydroxide down‐regulates T helper 2 responses by allergen‐stimulated human peripheral blood mononuclear cells

S. Durham, S. Durham, L. Wilcock, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa.

S. Durham, M. Jacobson, K. Nouri-Aria, 2008, The Journal of allergy and clinical immunology.

IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.

S. Durham, M. Jacobson, K. Nouri-Aria, 2005, The Journal of allergy and clinical immunology.

Basophils in human allergen-induced late-phase responses

S. Durham, K. Nouri-Aria, 2004 .

Allergic and Non-Allergic Rhinitis

S. Durham, H. Saleh, N. Orban, 2009 .

Allergen immunotherapy and tolerance.

S. Durham, M. Shamji, Tomokazu Matsuoka, 2013, Allergology international : official journal of the Japanese Society of Allergology.

Series : Immunotherapy and Tolerance — Cutting Edge Allergen Immunotherapy and Tolerance

S. Durham, M. Shamji, Tomokazu Matsuoka, 2013 .

Allergen immunotherapy for allergic respiratory diseases

S. Durham, A. Cappella, 2012, Human vaccines & immunotherapeutics.

Mechanisms of immunotherapy to aeroallergens

S. Durham, M. Shamji, M. Shamji, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression

S. Durham, A. Kay, A. Kay, 1997, Immunology.

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

S. Durham, S. Till, J. Francis, 2003, The Journal of allergy and clinical immunology.

Mechanisms of immunotherapy.

S. Durham, S. Till, K. Nouri-Aria, 2004, The Journal of allergy and clinical immunology.

Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2‐type inflammation but no evidence of remodelling

S. Durham, M. Jacobson, K. Nouri-Aria, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Rhinitis , sinusitis , and upper airway disease SQ-standardized sublingual grass immunotherapy : Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

S. Durham, R. Dahl, G. Scadding, 2012 .

Local allergic rhinitis: concept, pathophysiology, and management.

S. Durham, W. Fokkens, J. Mullol, 2012, The Journal of allergy and clinical immunology.

T follicular helper (Tfh) cells in normal immune responses and in allergic disorders

S. Durham, G. Marone, G. Varricchi, 2016, Allergy.

The CX3C chemokine fractalkine in allergic asthma and rhinitis.

S. Durham, M. Humbert, E. Varga, 2003, The Journal of allergy and clinical immunology.

Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis

A. Sheikh, G. Canonica, S. Durham, 2012 .

Sublingual immunotherapy for treating allergic conjunctivitis.

A. Sheikh, G. Canonica, S. Durham, 2011, The Cochrane database of systematic reviews.

Grass pollen immunotherapy for treatment of allergic rhinitis

S. Durham, S. Till, A. Slovick, 2014, BMJ : British Medical Journal.

Specific immunotherapy for latex allergy

S. Durham, M. Calderón, M. Makatsori, 2017 .

Systematic reviews of sublingual immunotherapy (SLIT)

S. Durham, M. Calderón, S. Radulovic, 2011, Allergy.

European Academy of Allergy and Clinical Immunology task force report on ‘dose–response relationship in allergen‐specific immunotherapy’

P. Demoly, S. Durham, G. Passalacqua, 2011, Allergy.

Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta‐analysis

A. Sheikh, G. Canonica, M. Calderon, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

NHS allergy services in the UK: proposals to improve allergy care.

S. Durham, P. Ewan, 2002, Clinical medicine.

2019 ARIA Care pathways for allergen immunotherapy

A. Sheikh, H. Schünemann, J. Bousquet, 2019, Allergy.

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

H. Schünemann, J. Bousquet, T. Zuberbier, 2019, Journal of thoracic disease.

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Rosalind W. Picard, D. Ryan, A. Sheikh, 2018, Clinical and Translational Allergy.

Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)

S. Durham, V. Lund, C. Hopkins, 2018, Trials.

Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond.

J. Bousquet, T. Casale, P. Demoly, 2011, The Journal of allergy and clinical immunology.

Allergic rhinitis and its impact on asthma update: allergen immunotherapy.

S. Durham, G. Passalacqua, 2007, The Journal of allergy and clinical immunology.

Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma.

S. Durham, A. Kay, Q. Hamid, 1993, The Journal of allergy and clinical immunology.

Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.

J. Bousquet, C. Bachert, S. Durham, 2006, Respiratory medicine.

Allergy and Clinical Immunology Services in Europe *

R. Gerth van Wijk, J. Lötvall, S. Bonini, 2006, Allergy.

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

S. Durham, R. Mösges, Y. Yarin, 2018, Allergy.

Development and validation of combined symptom‐medication scores for allergic rhinitis *

T. Zuberbier, T. Casale, Á. Cruz, 2021, Allergy.

Reply to the Letter by Dr Fleming Madsen (EAACI ‘Standards for practical allergen‐specific immunotherapy’)

J. Bousquet, S. Durham, G. Passalacqua, 2008, Allergy.

Allergen injection immunotherapy for seasonal allergic rhinitis.

A. Sheikh, S. Durham, M. Calderón, 2007, The Cochrane database of systematic reviews.

Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells

S. Durham, P. Ashton‐Rickardt, M. Shamji, 2017, The Journal of allergy and clinical immunology.

Perspectives on Geohistorical Data among Oyster Restoration Professionals in the United States

S. Durham, G. Dietl, 2013 .

Regulatory T cells and allergic disease.

S. Durham, K. Nouri-Aria, 2008, Inflammation & allergy drug targets.

Immunotherapy and allergic inflammation

S. Durham, A. Kay, M. Jacobson, 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

The effect of sleep deprivation and exercise on reaction threshold in peanut-allergic adults: a randomised controlled study.

J. Wason, C. Mills, S. Durham, 2019, The Journal of allergy and clinical immunology.

Cardiovascular changes during peanut-induced allergic reactions in human subjects

S. Durham, J. Bartra, P. Turner, 2020, The Journal of allergy and clinical immunology.

Specific allergen immunotherapy for the treatment of atopic eczema.

H. Williams, S. Durham, M. Calderón, 2016, The Cochrane database of systematic reviews.

CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge

S. Durham, S. Till, C. Pilette, 2004, European Respiratory Journal.

House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care [ISRCTN63308372]

S. Durham, B. Sibbald, B. Hurwitz, 2002, BMC family practice.

House dust mite barrier bedding for childhood asthma : randomised placebo controlled trial in primary care [ ISRCTN 63308372 ]

A. Sheikh, S. Durham, B. Sibbald, 2015 .

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement

P. Howarth, H. Schünemann, J. Bousquet, 2011, Allergy.

Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.

S. Durham, A. Kay, Q. Hamid, 1992, Journal of immunology.

Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.

S. Durham, M. Penagos, 2022, Allergy and asthma proceedings.

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial

C. Bachert, S. Durham, M. Calderón, 2018, Allergy.

Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness.

S. Durham, A. Kay, M. Jacobson, 1991, The Journal of allergy and clinical immunology.

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

S. Durham, Q. Hamid, A. Kay, 1993, The Journal of clinical investigation.

Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

S. Durham, A. Kay, Q. Hamid, 1995, American journal of respiratory cell and molecular biology.

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells.

S. Durham, A. Kay, M. Jacobson, 1992, The Journal of allergy and clinical immunology.

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.

J. Bousquet, G. Canonica, P. Demoly, 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma.

S. Durham, M. Humbert, A. Kay, 1997, American journal of respiratory and critical care medicine.

The temporal relationship between increases in airway responsiveness to histamine and late asthmatic responses induced by occupational agents.

S. Durham, B. Graneek, R. Hawkins, 1987, The Journal of allergy and clinical immunology.

Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma.

S. Durham, A. Wardlaw, G. Menz, 1993, The Journal of allergy and clinical immunology.

IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

S. Durham, A. Kay, S. Ying, 1998, The Journal of allergy and clinical immunology.

Allergen Immunotherapy and

S. Durham, T. Matsuoka, 2013 .

Update on mechanisms of allergen injection immunotherapy

S. Durham, L. James, S. Durham, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Increased expression of high affinity ige (FcεRI) receptor-α chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma

S. Durham, M. Humbert, A. Kay, 1998 .

Enhanced expression of high-affinity IgE receptor (FcϵRI) α chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells

S. Durham, M. Humbert, A. Kay, 1997 .

Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen‐induced late cutaneous responses

S. Durham, S. Walker, M. Jacobson, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergic inflammation

S. Durham, 1993, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils.

S. Durham, A. Kay, D. Robinson, 1992, The American review of respiratory disease.

Late asthmatic responses.

S. Durham, 1990, Respiratory medicine.

Leukocyte activation in allergen-induced late-phase asthmatic reactions.

S. Durham, A. Kay, M. Carroll, 1984, The New England journal of medicine.

Immunologic studies in allergen-induced late-phase asthmatic reactions.

S. Durham, A. Kay, T. Lee, 1984, The Journal of allergy and clinical immunology.

Pathogenesis of rhinitis

S. Durham, A. Eifan, 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Topical corticosteroid inhibits interleukin‐4, ‐5 and ‐13 in nasal secretions following allergen challenge

S. Durham, P. Barnes, T. Williams, 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.

S. Durham, P. Barnes, S. Kharitonov, 1997, The Journal of allergy and clinical immunology.

Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling.

S. Durham, M. Jacobson, A. Eifan, 2015, American journal of respiratory and critical care medicine.

IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.

S. Durham, M. Jacobson, S. Rak, 1997, American journal of respiratory cell and molecular biology.

CXCR1+CD4+ T Cells in Human Allergic Disease1

S. Durham, M. Jacobson, S. Till, 2004, The Journal of Immunology.

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

S. Durham, A. Frew, C. Corrigan, 2006, The Journal of allergy and clinical immunology.

Effect of cyclosporin A on the allergen-induced late asthmatic reaction.

S. Durham, A. Kay, O. Kon, 1997, Thorax.

Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells

C. Mackay, S. Durham, A. Kay, 1997, European journal of immunology.

The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences.

S. Durham, M. Humbert, G. Menz, 1999, Immunology today.

Mechanisms of mucosal inflammation in the nose and lungs.

S. Durham, 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

S. Durham, A. Wardlaw, A. Kay, 1990, The American review of respiratory disease.

Postnasal drip and chronic cough: An open interventional study.

S. Durham, K. Chung, A. Torrego, 2009, Respiratory medicine.

PREDNISOLONE TREATMENT IN ASTHMA IS ASSOCIATED WITH MODULATION OF BRONCHOALVEOLAR LAVAGE CELL IL-4, IL-5 AND IFN-GAMMA CYTOKINE GENE EXPRESSION

S. Durham, A. Kay, Q. Hamid, 1993 .

TNF alpha mRNA expression in allergic inflammation.

S. Durham, A. Kay, Q. Hamid, 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy.

S. Durham, K. Takatsu, A. Kay, 1993, The American review of respiratory disease.

Acid anhydrides and asthma.

S. Durham, K. Venables, M. Topping, 1987, International archives of allergy and applied immunology.

Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma.

S. Durham, M. Humbert, C. Corrigan, 1996, The European respiratory journal.

Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.

S. Durham, A. Kay, Q. Hamid, 1996, American journal of respiratory and critical care medicine.

Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness.

S. Durham, A. Kay, D. Robinson, 1993, Thorax.

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions.

S. Durham, A. Kay, G. Gleich, 1989, The American review of respiratory disease.

Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals

M. Calderon, A. Togias, S. Durham, 2015, Allergy.

IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients.

S. Durham, K. Chung, A. Cavani, 2013, The Journal of allergy and clinical immunology.

Effect of intranasal corticosteroid treatment on asthma in children and adults

S. Durham, S. Durham, Stephen R. Durham, 1999, Allergy.

Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects.

S. Durham, A. Wardlaw, Q. Hamid, 1991, International archives of allergy and applied immunology.

Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

S. Durham, A. Kay, D. Robinson, 1997, Journal of immunology.

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

T. Casale, S. Durham, M. Calderón, 2017, Current Allergy and Asthma Reports.

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

S. Durham, M. Calderón, L. Turka, 2012, Journal of immunological methods.

Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium

S. Durham, S. Walker, M. Jacobson, 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Granulocyte/Macrophage–Colony Stimulating Factor in Allergen–Induced Rhinitis: Cellular Localization, Relation to Tissue Eosinophilia and Influence of Topical Corticosteroid

S. Durham, M. Jacobson, K. Nouri-Aria, 1998, International Archives of Allergy and Immunology.

Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects

S. Durham, A. Wardlaw, A. Kay, 1991, The Journal of experimental medicine.

Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells.

S. Durham, M. Humbert, A. Kay, 1997, The Journal of allergy and clinical immunology.

Evidence for Th2-type T helper cell control of allergic disease in vivo

S. Durham, Q. Hamid, A. Kay, 2004, Springer Seminars in Immunopathology.

Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma.

S. Durham, A. Kay, Q. Hamid, 1993, The Journal of allergy and clinical immunology.

Inhibition of nasal mucosal eosinophils after immunotherapy is associated with a decrease in interleukin-13 mRNA and vascular cell adhesion molecule-1 expression

S. Durham, S. Walker, M. Jacobson, 2004 .

IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease.

S. Durham, M. Humbert, A. Kay, 1997, The Journal of allergy and clinical immunology.

Secretion of the eosinophil‐active cytokines interleukin‐5, granulocyte/macrophage colonystimulating factor and interleukin‐3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopics asthmatics, and atopic and nonatopic controls

S. Durham, M. Humbert, A. Kay, 1995, European journal of immunology.

Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.

S. Durham, A. Kay, Q. Hamid, 1995, American journal of respiratory cell and molecular biology.

Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.

S. Durham, A. Kay, Q. Hamid, 1992, Journal of immunology.

T Cells from Human Allergen-Induced Late Asthmatic Responses Express IL-12 Receptor β2 Subunit mRNA and Respond to IL-12 In Vitro1

S. Durham, E. Varga, S. Till, 2000, The Journal of Immunology.

Vitro2 Subunit mRNA and Respond to IL-12 In b Receptor Asthmatic Responses Express IL-12 T Cells from Human Allergen-Induced Late

S. Durham, E. Varga, S. Till, 2000 .

Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.

S. Durham, A. Kay, Q. Hamid, 1998, The Journal of allergy and clinical immunology.

Asthma phenotypes and IgE responses

S. Durham, P. Chanez, C. Pilette, 2016, European Respiratory Journal.

Relationship between mediator release from human lung mast cells in vitro and in vivo.

P. Howarth, S. Durham, S. Holgate, 1985, International archives of allergy and applied immunology.

The role of allergen‐specific IgE, IgG and IgA in allergic disease

S. Durham, R. Valenta, V. Verhasselt, 2021, Allergy.

Role of IL‐35 in sublingual allergen immunotherapy

S. Durham, P. Ashton‐Rickardt, M. Shamji, 2019, The Journal of allergy and clinical immunology.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.

S. Durham, E. Meltzer, H. Nelson, 2016, The Journal of allergy and clinical immunology.

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.

S. Durham, M. Calderón, C. Schmidt‐Weber, 2016, The Journal of allergy and clinical immunology.

Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma

S. Durham, R. Dahl, H. Nolte, 2015, Allergy.

Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy.

S. Durham, M. Shamji, G. Scadding, 2014, The Journal of allergy and clinical immunology.

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

A. Sheikh, J. Virchow, R. Mosges, 2012, Clinical and Translational Allergy.

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

S. Durham, L. James, S. Walker, 2011, The Journal of allergy and clinical immunology.

T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non‐allergic controls and following allergen immunotherapy

S. Durham, S. Till, C. Lloyd, 2007, Allergy.

Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study

William H. Yang, S. Durham, S. Rak, 2007, Quality of Life Research.

Standards for practical allergen‐specific immunotherapy

J. Bousquet, G. Canonica, S. Durham, 2006, Allergy.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

S. Durham, R. Dahl, A. Kapp, 2006, Journal of Allergy and Clinical Immunology.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

William H. Yang, S. Durham, S. Rak, 2006, The Journal of allergy and clinical immunology.

Is occupational asthma to diisocyanates a non-IgE-mediated disease?

P. Cullinan, S. Durham, M. Jacobson, 2006, The Journal of allergy and clinical immunology.

Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis *

S. Durham, D. Wilson, Duncan R. Wilson, 2005, Allergy.

Requirements for medications commonly used in the treatment of allergic rhinitis

J. Bousquet, C. Bachert, G. Canonica, 2003, Allergy.

Local ige synthesis in allergic rhinitis and asthma

S. Durham, L. Smurthwaite, 2002, Current allergy and asthma reports.

Persistent IgE synthesis in the nasal mucosa of hay fever patients

S. Durham, H. Gould, T. Merrett, 2001, European journal of immunology.

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.

S. Durham, G. Pajno, S. Walker, 2001, The Journal of allergy and clinical immunology.

Local synthesis of ϵ germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure

S. Durham, S. Muro, Q. Hamid, 2000 .

Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure.

S. Durham, S. Muro, Q. Hamid, 2000, The Journal of allergy and clinical immunology.

Assessment by Nasal Biopsy of Long-Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis

S. Durham, V. Lund, K. Nolop, 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Skin prick testing in general practice: a pilot study.

S. Durham, B. Sibbald, G. Barnes, 1997, Journal of advanced nursing.

Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.

S. Durham, P. Barnes, S. Kharitonov, 1997, The Journal of allergy and clinical immunology.

Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses.

C. Bachert, S. Durham, G. Holtappels, 2019, The Journal of allergy and clinical immunology.

Development of cockroach immunotherapy by the Inner-City Asthma Consortium.

W. Busse, G. O'Connor, A. Togias, 2014, The Journal of allergy and clinical immunology.

Blood eosinophils and eosinophil-derived proteins in allergic asthma.

S. Durham, D. Loegering, G. Gleich, 1989, The Journal of allergy and clinical immunology.

Immunotherapy for Allergy

S. Durham, E. Steveling-Klein, 2021 .

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

S. Durham, A. Kay, Q. Hamid, 1996, The Journal of allergy and clinical immunology.

ONE AIRWAY : THE LINK BETWEEN ALLERGIC RHINITIS AND ASTHMA * —

S. Durham, 2022 .

Application of monoclonal antibodies against major basic protein (BMK‐13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma

S. Durham, A. Kay, R. Moqbel, 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

T Lymphocyte/Eosinophil Interactions in Atopic Asthma: Critical Role for Interleukin-5

S. Durham, Q. Hamid, A. Tsicopoulos, 1993 .

Upregulation of αGM-CSF-receptor in nonatopic asthma but not in atopic asthma ☆ ☆☆ ★ ★★

S. Durham, M. Humbert, J. Tavernier, 1997 .

Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma.

S. Durham, M. Humbert, J. Tavernier, 1997, The Journal of allergy and clinical immunology.

Falls in peripheral eosinophil counts parallel the late asthmatic response.

S. Durham, M. K. Benson, W. Cookson, 1989, The American review of respiratory disease.

Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.

S. Durham, M. Humbert, R. Pfister, 1997, Journal of immunology.

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

S. Durham, P. Smith, A. Burks, 2014, The Journal of allergy and clinical immunology.

Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma.

S. Durham, M. Humbert, R. Pfister, 2001, The Journal of allergy and clinical immunology.

Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation

S. Durham, D. Altmann, R. Boyton, 2013, Thorax.

Geohistorical records indicate no impact of the Deepwater Horizon oil spill on oyster body size

S. Durham, G. Dietl, 2016, Royal Society Open Science.

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy

S. Durham, M. Calderón, A. Frew, 2012, Allergy.

T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

S. Durham, A. Kay, Q. Hamid, 1994, Immunology.

Reduced T‐bet in addition to enhanced STAT6 and GATA3 expressing T cells contribute to human allergen‐induced late responses

S. Durham, M. Jacobson, K. Nouri-Aria, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Single dose topical corticosteroid inhibits IL‐5 and IL‐13 in nasal lavage following grass pollen challenge

S. Durham, P. Barnes, T. Williams, 2005, Allergy.

CCR4 in human allergen‐induced late responses in the skin and lung

S. Durham, E. Varga, M. Jacobson, 2002, European journal of immunology.

Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis

S. Durham, M. Humbert, A. Kay, 1998, Thorax.

Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein

S. Durham, A. Kay, C. Corrigan, 1996, European journal of immunology.

Co-expression of CD25 and CD3 in atopic allergy and asthma.

S. Durham, A. Kay, Q. Hamid, 1992, Immunology.

Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge.

S. Durham, M. Humbert, A. Kay, 1998, American journal of respiratory and critical care medicine.

275 Cytokine mRNA profile and T-cell activation in bronchoalveolar lavage (BAL) cells from atopic asthmatics and controls

S. Durham, A. Kay, Q. Hamid, 1991 .

325 Falls in eosinophils parallel the late asthmatic response and associated increases in airway responsivehess

S. Durham, M. K. Benson, W. Cookson, 1988 .

Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial.

C. Bachert, S. Durham, P. Hellings, 2018, The Journal of allergy and clinical immunology.

Sustained effect of SQ‐standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life

S. Durham, R. Dahl, M. Calderón, 2009, Allergy.

Diurnal variation in serum cortisol concentrations in asthmatic subjects after allergen inhalation.

S. Durham, J. Keenan, M. K. Benson, 1989, Thorax.

T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis.

S. Durham, A. Kay, Q. Hamid, 1993, American journal of respiratory cell and molecular biology.

Rhinitis: Mechanisms and Management

S. Durham, R. Naclerio, N. Mygind, 1998 .

Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma

S. Durham, M. Calderón, A. Eifan, 2013, Expert opinion on biological therapy.

Sublingual immunotherapy: what have we learnt from the ‘big trials’?

S. Durham, 2008, Current opinion in allergy and clinical immunology.

Latex allergy in a dental nurse : Late nasal response is associated with eosinophil recruitment and T helper 2 cell type cytokine mRNA expression

P. Cullinan, S. Durham, M. Jacobson, 1998 .

Expression of the IL-4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects.

S. Durham, M. Humbert, T. Kotsimbos, 1998, The Journal of allergy and clinical immunology.

Immunologic changes associated with allergen immunotherapy.

S. Durham, S. Till, 1998, The Journal of allergy and clinical immunology.

ACTIVATION OF CD41 T CELLS AND INCREASED IL-4, IL-5 AND GM-CSF MRNA POSITIVE CELLS IN BRONCHOALVEOLAR LAVAGE FLUID (BAL) 24 H AFTER ALLERGEN INHALATION CHALLENGE OF ATOPIC ASTHMATIC PATIENTS

S. Durham, A. Kay, Q. Hamid, 1993 .

Enhancement of leukocyte cytotoxicity after exercise-induced asthma.

S. Durham, A. Kay, M. Carroll, 1986, The American review of respiratory disease.

Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma.

S. Durham, A. Bentley, A. B. Kay, 1994, Journal of investigational allergology & clinical immunology.

Originalarbeit Clinical efficacy and immunological response in children is similar to that of adults after the first treatment season with SQ-standardized grass allergy immunotherapy tablet in two randomized trials

S. Durham, A. Bufe, B. Tholstrup, 2013 .

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

S. Durham, M. Calderón, L. James, 2008, The Journal of allergy and clinical immunology.

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

S. Durham, A. Kay, M. Gaga, 1991, BMJ.

Rhinitis with negative skin tests and absent serum allergen-specific IgE: more evidence for local IgE?

S. Durham, L. James, 2009, The Journal of allergy and clinical immunology.

Tradition and innovation: finding the right balance.

S. Durham, 2007, The Journal of allergy and clinical immunology.

231 Immunological studies of antigen-induced late asthmatic reactions

S. Durham, A. Kay, M. Brown, 1983 .

UK Immunotherapy Study: Reanalysis by a combined symptom and medication score.

S. Durham, O. Pfaar, A. Frew, 2018, The Journal of allergy and clinical immunology.

Novel approaches and perspectives in allergen immunotherapy

S. Durham, E. Valovirta, O. Pfaar, 2017, Allergy.

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

S. Durham, R. Dahl, G. Scadding, 2010, The Journal of allergy and clinical immunology.

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

B. Yawn, W. Busse, H. Schünemann, 2010, Allergy.

Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction.

S. Durham, A. Kay, M. Carroll, 1985, The Journal of allergy and clinical immunology.

Local and systemic effects of cat allergen nasal provocation

A. Togias, S. Durham, D. Phippard, 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergen‐induced recruitment of FcσRI+ eosinophils in human atopic skin

S. Durham, M. Humbert, S. Ying, 1997 .

Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals.

S. Durham, Q. Hamid, J. North, 1994, The Journal of allergy and clinical immunology.

Perspectives in allergen immunotherapy: 2019 and beyond

J. Virchow, R. Van Ree, S. Bonini, 2019, Allergy.

Expression of ε germ‐line gene transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid

S. Durham, Q. Hamid, M. Jacobson, 1997 .

T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-41

S. Durham, S. Till, T. Williams, 2001, The Journal of Immunology.

Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

S. Durham, S. Till, E. James, 2014, The Journal of allergy and clinical immunology.

A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness

S. Durham, S. Walker, F. Hanotte, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Induction of ‘blocking’ IgG antibodies during immunotherapy

S. Durham, P. Wachholz, S. R. Durham, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses.

S. Durham, M. K. Benson, W. Cookson, 1988, The Journal of allergy and clinical immunology.

Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.

S. Durham, G. Pajno, S. Walker, 2001, The Journal of allergy and clinical immunology.

responsiveness . symptoms , lung function , and bronchial with atopic asthma : relation to asthma bronchoalveolar lavage fluid from patients Activated memory T helper cells in

S. Durham, A. Kay, D. Robinson, 2022 .

IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens

S. Durham, L. James, G. Lack, 2015, The Journal of allergy and clinical immunology.

Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1 : Th2 cytokine ratios

S. Durham, S. Walker, S. Till, 2002, Immunology.

T lymphocytes in asthma: bronchial versus peripheral responses.

S. Durham, S. Till, C. Corrigan, 2000, The Journal of allergy and clinical immunology.

IL‐5 production by allergen‐stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis

S. Durham, J. Lamb, A. Kay, 1997, Clinical and experimental immunology.

Allergen avoidance measures. British Thoracic Society.

S. Durham, 1996, Respiratory medicine.

Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms

S. Durham, S. Till, A. Douiri, 2017, The Journal of allergy and clinical immunology.

Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes

S. Durham, M. Calderón, L. James, 2015, Clinical and Translational Allergy.

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge

A. Togias, S. Durham, D. Phippard, 2015, Allergy.

Chapter 1 – Principles of Allergy Diagnosis

S. Durham, M. Church, 2006 .

Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses

S. Durham, M. Calderón, M. Jacobson, 2005 .

Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT)

S. Durham, D. Na, J. Larsen, 2005 .

Grass pollen immunotherapy (IT) decreases IL-9 mRNA expressing cells in the nasal mucosa during the pollen season

S. Durham, M. Jacobson, K. Nouri-Aria, 2004 .

Grass pollen immunotherapy for two years has sustained effects during two years double-blind placebo-controlled withdrawal of treatment

S. Durham, S. Walker, M. Jacobson, 2003 .

ABC of allergies: Summer hay fever

S. Durham, 1998, BMJ.

Advances in the Treatment of Allergic Rhinitis

S. Durham, 1993 .

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids

S. Durham, K. Chung, P. Barnes, 1998, Thorax.

144 Airway hyperreactivity and mediator release in clinical models of asthma

P. Howarth, S. Durham, S. Holgate, 1985 .

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials

S. Durham, S. Durham, J. Andersen, 2011, Allergy.

Effect of grass pollen immunotherapy with Alutard SQ® on quality of life in seasonal allergic rhinoconjunctivitis

S. Durham, A. Frew, C. Corrigan, 2007, Allergy.

Adjuvants for allergen immunotherapy: experimental results and clinical perspectives

S. Durham, J. Francis, 2004, Current opinion in allergy and clinical immunology.

The prevalence of PFS and prevalence and characteristics of reported food allergy; a survey of UK adults aged 18–75 incorporating a validated PFS diagnostic questionnaire

S. Durham, I. Small, K. Gruffydd-Jones, 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

S. Durham, M. Humbert, R. Pfister, 2001 .

Local IgE Production

S. Durham, H. Gould, L. Smurthwaite, 2000, American journal of rhinology.

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

A J Wardlaw, S. Durham, A. Wardlaw, 1991, The Journal of clinical investigation.

Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.

S. Durham, E. Varga, Q. Hamid, 2000, The Journal of allergy and clinical immunology.

Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization

J. Kemp, P. Howarth, J. Bousquet, 2002 .

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial

S. Durham, S. Walker, M. Jacobson, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Broad Immunglobulin G Repertoire in Chronic Rhinosinusitis with Nasal Polyps regulates pro-inflammatory IgE responses

C. Bachert, S. Durham, G. Holtappels, 2019 .

Introduction

S. Durham, 1998 .

The many faces of asthma. Introduction. Proceedings from a symposium held at the annual meeting of the European Academy of Allergology and Clinical Immunology in Rhodes Greece, June 1997.

S. Durham, 1998, Allergy.

Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics.

S. Durham, E. Varga, S. Till, 2002, American journal of respiratory and critical care medicine.

Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma.

P Maestrelli, S. Durham, L. Fabbri, 1992, The Journal of allergy and clinical immunology.

Cellular aspects of occupational asthma : Immunological studies in isocyanate exposed subjects Prepared by the National Heart and Lung

P. Cullinan, S. Durham, Meinir G. Jones, 2003 .

Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions.

S. Durham, A. Kay, S. Ying, 1995, International archives of allergy and immunology.

294 Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: Comparison with atopic non-asthma and relationship to bronchial hyperresponsiveness

S. Durham, A. Kay, M. Jacobson, 1991 .

Efficacy and safety of the SQ‐standardized grass allergy immunotherapy tablet in mono‐ and polysensitized subjects

S. Durham, M. Blaiss, H. Nelson, 2013, Allergy.

Innate lymphoid cells: The missing part of a puzzle in food allergy

S. Durham, C. Akdis, K. Nadeau, 2020, Allergy.

Nasal allergen‐neutralizing IgG4 antibodies block IgE‐mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy

S. Durham, M. Calderón, G. Marone, 2019, The Journal of allergy and clinical immunology.

Allergen avoidance measures

S. Durham, 1996 .

Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.

S. Durham, M. Humbert, G. Opdenakker, 1997, American journal of respiratory cell and molecular biology.

43 Increases in RANTES mRNA and protein in the nasal mucosa and nasal secretions in hay fever patients after allergen challenge

S. Durham, M. Jacobson, F. O'brien, 1996 .

The allergen specificity of allergen immunotherapy—doubt no more

S. Durham, 2019, Allergy.

ABC of allergies: Perennial rhinitis

S. Durham, I. Mackay, S R Durham, 1998, British medical journal.

Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.

S. Durham, M. Jacobson, S. Rak, 1997, The Journal of allergy and clinical immunology.

Cytokine expression during allergen‐induced late nasal responses: IL‐4 and IL‐5 mRNA is expressed early (at 6 h) predominantly by eosinophils

S. Durham, F. O'brien, W. Noble, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis.

S. Durham, E. Varga, M. Jacobson, 1999, The European respiratory journal.

Basophil recruitment and IL-4 production during human allergen-induced late asthma.

S. Durham, E. Varga, M. Jacobson, 2001, The Journal of allergy and clinical immunology.

Assessment of airway inflammation: an overview.

D. Postma, P. O'Byrne, S. Durham, 1998, The European respiratory journal. Supplement.

New insights into the mechanisms of immunotherapy

S. Durham, 2006, European Archives of Oto-Rhino-Laryngology.

Current Status of Inununotherapy

S. Durham, 1993 .

Synchronous immune alterations mirror clinical response during allergen immunotherapy

A. Togias, S. Durham, S. Till, 2017, The Journal of allergy and clinical immunology.

Mechanisms of Sublingual Immunotherapy

S. Durham, G. Scadding, 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

Cochrane Systematic Review: Safety Profile of Sublingual Immunotherapy (SLIT) for Allergic Rhinitis (AR)

S. Durham, M. Calderón, S. Radulovic, 2008 .

Sublingual immunotherapy for allergic Rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.

S. Durham, M. Calderón, M. Penagos, 2008, Clinical allergy and immunology.

British Thoracic Society Asthma Guidelines Reviews Allergen avoidance measures

S. Durham, 1996 .

Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy

S. Durham, W. Fokkens, M. Jacobson, 2001, Allergy.

Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis.

S. Durham, Q. Hamid, S. Frenkiel, 1998, American journal of respiratory cell and molecular biology.

One hundred years of allergen immunotherapy: time to ring the changes.

S. Durham, D. Leung, 2011, The Journal of allergy and clinical immunology.

Immunotherapy for hayfever.

S. Durham, S. Walker, 2000, Chemical immunology.

Mechanisms of sublingual immunotherapy.

S. Durham, G. Scadding, 2011, Immunology and allergy clinics of North America.

Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.

C. Bachert, S. Durham, R. Mösges, 2019, The Journal of allergy and clinical immunology.

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?

S. Durham, U. Sahiner, 2019, Front. Immunol..

Immunotherapy and Asthma

S. Durham, Moises A. Calderon‐Zapata, 2005 .

Assessment of airway inflammation

D. Postma, P. O'Byrne, S. Durham, 1998 .

6 – Principles of allergy diagnosis

S. Durham, R. Peebles, M. Church, 2012 .

Mechanisms of immunotherapy: IgG revisited

S. Durham, P. Wachholz, 2004, Current opinion in allergy and clinical immunology.

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.

S. Durham, M. Larché, M. Shamji, 2006, Journal of immunological methods.

Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.

S. Durham, S. Till, P. Wachholz, 2003, The Journal of allergy and clinical immunology.

Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?

S. Durham, H. Nelson, 2017, The journal of allergy and clinical immunology. In practice.

Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3‐expressing cells and elevated allergen‐specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E‐facilitated allergen binding to B cells

S. Durham, M. Jacobson, K. Nouri-Aria, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product.

S. Durham, A. Kay, P. Kimmitt, 1995, Journal of immunology.

Allergen immunotherapy: past, present and future

S. Durham, M. Shamji, 2022, Nature Reviews Immunology.

A Nonallergenic Birch Pollen Allergy Vaccine Consisting of Hepatitis PreS–Fused Bet v 1 Peptides Focuses Blocking IgG toward IgE Epitopes and Shifts Immune Responses to a Tolerogenic and Th1 Phenotype

S. Durham, R. Valenta, P. Valent, 2013, The Journal of Immunology.

Allergen Immunotherapy: A Centenary Celebration

S. Durham, H. Nelson, 2011, The World Allergy Organization journal.

The Laboratory Investigation of Mediators and Inflammatory Cells in Asthma and Rhinitis

S. Durham, A. Kay, 1985, Clinics in Immunology and Allergy.

Immunologic responses to subcutaneous allergen immunotherapy.

S. Durham, S. Till, 2008, Clinical allergy and immunology.

Monophosphoryl lipid A (MPL®) * promotes allergen‐induced immune deviation in favour of Th1 responses

S. Durham, F. Puggioni, S. Durham, 2005, Allergy.

Serum immunologic markers for monitoring allergen-specific immunotherapy.

S. Durham, L. James, M. Shamji, 2011, Immunology and allergy clinics of North America.

Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen‐specific and may result in part from expansion of effector T cells among the CD25+ population

S. Durham, K. Mackerness, M. Aizen, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray.

S. Durham, I. Mackay, J. Rowe-Jones, 2005, Rhinology.

RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia.

S. Durham, Q. Hamid, M. Jacobson, 1997, American journal of respiratory and critical care medicine.

The ideal nasal corticosteroid: balancing efficacy, safety and patient preference

S. Durham, 2002 .

Epitope speciﬁcity determines cross-protection of a SIT-induced IgG 4 antibody

S. Durham, R. Valenta, L. James, 2015 .

Inhibition of CD23‐dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules

S. Durham, R. Valenta, I. Kimber, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis

Brian Hurwitz, Aziz Sheikh, Gopalakrishnan Netuveli, 2005, The Lancet.

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma.

S. Durham, M. Humbert, A. Kay, 1998, American journal of respiratory and critical care medicine.

Cytokines. 3. Cytokines in asthma.

S. Durham, A. Kay, D. Robinson, 1993, Thorax.

A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T‐Helper Type 2 and B‐Cell Responses in Grass Pollen‐induced Allergic Inflammation

S. Durham, U. Kishore, M. Shamji, 2017, American journal of respiratory and critical care medicine.

IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.

S. Durham, L. Wilcock, J. Francis, 2006, Immunology and allergy clinics of North America.

Allergen immunotherapy (desensitisation) for allergic diseases.

S. Durham, 2006, Clinical medicine.

Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy.

A. Togias, S. Durham, G. Nepom, 2021, The Journal of allergy and clinical immunology.

Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.

Feng Q. He, S. Durham, W. Fokkens, 2021, Immunity.

Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)

S. Durham, S. Till, A. Douiri, 2013, Clinical and Translational Allergy.

Sustained effects of grass pollen AIT

S. Durham, S. Durham, 2011, Allergy.

Blocking IgG Activity and Mucosal and Peripheral IL-10 Responses Grass Pollen Immunotherapy Induces

S. Durham, S. Walker, M. Jacobson, 2004 .

Molecular pathology of allergic disease. II: Upper airway disease.

S. Durham, Q. Hamid, L. Cameron, 2000, The Journal of allergy and clinical immunology.

658 Immunohistology of allergen-induced late nasal responses

S. Durham, A. Kay, M. Jacobson, 1991 .

Neutrophil Extracellular Traps in Asthma: Friends or Foes?

S. Durham, G. Marone, M. Shamji, 2022, Cells.

Time course of serum inhibitory activity for facilitated allergen–IgE binding during bee venom immunotherapy in children

S. Durham, E. Varga, W. Aberer, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Leucocyte activation initiated by IgE-dependent mechanisms in relation to helminthic parasitic disease and clinical models of asthma.

S. Durham, A. Kay, O. Cromwell, 1985, International archives of allergy and applied immunology.

A randomised placebo-controlled trial investigating efficacy and mechanisms of low-dose intradermal allergen immunotherapy in treatment of seasonal allergic rhinitis

S. Durham, S. Till, A. Douiri, 2016 .

Tregs and allergic disease.

S. Durham, D. Robinson, M. Larché, 2004, The Journal of clinical investigation.

Immunological responses to allergen immunotherapy.

S. Durham, S. Till, 2004, Clinical allergy and immunology.

Sublingual immunotherapy for allergic rhinitis.

S. Durham, M. Calderón, S. Radulovic, 2010, The Cochrane database of systematic reviews.

Eosinophils and eosinophil-associated cytokines in allergic inflammation.

S. Durham, S. Ying, Q. Meng, 1997, International archives of allergy and immunology.

Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.

S. Durham, E. Minshall, Q. Hamid, 1998, The Journal of allergy and clinical immunology.

ENHANCED NEUTROPHIL AND MONOCYTE CYTO-TOXICITY AFTER EXERCISE INDUCED ASTHMA

S. Durham, A. Kay, M. Carroll, 1985 .

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

S. Durham, A. Kay, Q. Hamid, 1992, The New England journal of medicine.

Tcellsisincreased inallergic disease and associated with IL-5butnotI:FN-y expression

S. Durham, A. Kay, S. Till, 1997 .

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

P. Gergen, W. Busse, G. O'Connor, 2020, Journal of Allergy and Clinical Immunology.

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

S. Durham, Q. Hamid, S. Walker, 1997, The Journal of allergy and clinical immunology.

Changes in allergic inflammation associated with successful immunotherapy.

S. Durham, A. Kay, Q. Hamid, 1995, International archives of allergy and immunology.

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

S. Durham, H. Behrendt, A. Cavani, 2009, The Journal of clinical investigation.

Immunotherapy Is Allergen-Specific: A Double-Blind Trial of Mite or Timothy Extract in Mite and Grass Dual-Allergic Patients

S. Durham, A. Kay, S. Dreborg, 2011, International Archives of Allergy and Immunology.

Perennial rhinitis

S. Durham, H. Saleh, 2007, BMJ : British Medical Journal.

Rat-specific IgG and IgG4 antibodies associated with inhibition of IgE–allergen complex binding in laboratory animal workers

P. Cullinan, S. Durham, S. Schofield, 2014, Occupational and Environmental Medicine.

Asthma, Eosinophils, and Interleukin-5

S. Durham, Q. Hamid, D. Robinson, 2019, Eosinophils in Allergy and Inflammation.

Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness.

S. Durham, G. Menz, A. Kay, 1992, The American review of respiratory disease.

Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cells

S. Durham, F. Balkwill, Qin Wang, 2003, European journal of immunology.

173 Eosinophils, non-specific bronchial responsiveness, and allergen-induced late-phase asthmatic reactions

S. Durham, D. Loegering, A. Kay, 1985 .

Mollusk Assemblages As Records of Past and Present Ecological Status

S. Durham, G. Dietl, Jansen A. Smith, 2016, Front. Mar. Sci..

Delayed symptoms and orthostatic intolerance following peanut challenge

S. Durham, P. Turner, R. Boyle, 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Comparison of nasal allergen challenges with dissolved Timothy grass pollen tablets and aqueous extract

S. Durham, A. Eifan, G. Scadding, 2020, Allergy.

Local IgE production in nasal allergy.

S. Durham, Q. Hamid, H. Gould, 1997, International archives of allergy and immunology.

Identification of neutral endopeptidase mRNA in human nasal mucosa.

S. Durham, M. Kaliner, P. Barnes, 1993, Journal of applied physiology.

IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.

S. Durham, M. Humbert, R. Pfister, 1996, American journal of respiratory and critical care medicine.

Allergen-specific IgE is not detectable in the bronchial mucosa of nonatopic asthmatic patients.

S. Durham, Shih-Ying Wu, L. Ohm-Laursen, 2014, The Journal of allergy and clinical immunology.

Allergic Rhinitis Patients of Switch Recombination in the Nasal Mucosa Local Somatic Hypermutation and Class

S. Durham, Heather Coker, H. Gould, 2003 .

640 Immunotherapy suppresses T lymphocyte infiltration in the cutaneous late-phase reaction

S. Durham, A. Kay, M. Jacobson, 1991 .

274 Localization of cells expressing mRNA for the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen-induced cutaneous late-phase reactions in atopic patients

S. Durham, A. Wardlaw, A. Kay, 1991 .

Grass pollen immunotherapy alters chromatin landscape in circulating T follicular and regulatory cells.

S. Durham, K. Nadeau, G. Marone, 2020, The Journal of allergy and clinical immunology.

Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

T. Zuberbier, Á. Cruz, S. Durham, 2022, Clinical and translational allergy.

The upper respiratory tract

S. Durham, G. Sandhu, H. Saleh, 2012 .

Rapid determination of oyster lifespans and growth rates using LA-ICP-MS line scans of shell Mg/Ca ratios.

S. Durham, G. Dietl, D. Gillikin, 2017 .

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

Todor A Popov, D. Postma, A. Sheikh, 2012, The Journal of allergy and clinical immunology.

Rhinosinusitis: Establishing definitions for clinical research and patient care

C. Bachert, A. Togias, S. Durham, 2004, Journal of Allergy and Clinical Immunology.

Rhinosinusitis: Establishing definitions for clinical research and patient care

C. Bachert, A. Togias, S. Durham, 2004, Otolaryngology - Head and Neck Surgery.

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

J. Bousquet, C. Baena-Cagnani, G. Canonica, 2014, The World Allergy Organization journal.

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

C. Bachert, S. Durham, W. Fokkens, 2017, The Journal of allergy and clinical immunology.

Silk contact anaphylaxis

S. Durham, G. Scadding, I. Skypala, 2014, Contact dermatitis.

GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe

J. Bousquet, T. Zuberbier, C. Bachert, 2009, Allergy.

Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.

Vicki Seyfert-Margolis, Stephen R Durham, T. Casale, 2007, The Journal of allergy and clinical immunology.

Rhinitis, sinusitis and the yellow nail syndrome: a review of symptoms and response to treatment in 17 patients.

S. Durham, V. Cumberworth, I. Mackay, 1994, Clinical otolaryngology and allied sciences.

Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen‐induced rhinoconjunctivitis – an EAACI position paper

M. Sofiev, P. Demoly, R. Gerth van Wijk, 2017, Allergy.

Allergen-Specific IgG and IgG4 Autoanalyzer Performance and Utility In Assessing Immunotherapy (IT) Study Specimens

S. Durham, G. Lack, V. Seyfert-Margolis, 2008 .

Applications and mechanisms of immunotherapy in allergic rhinitis and asthma

S. Durham, M. Shamji, J. Kappen, 2017, Therapeutic advances in respiratory disease.

Epitope specificity determines cross‐protection of a SIT‐induced IgG4 antibody

S. Durham, R. Valenta, L. James, 2015, Allergy.

Inhibition of allergen‐dependent IgE activity by antibodies of the same specificity but different class

S. Durham, L. James, A. Beavil, 2015, Allergy.

Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy.

S. Durham, L. James, A. Beavil, 2012, The Journal of allergy and clinical immunology.

Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity1

S. Durham, S. Walker, M. Jacobson, 2004, The Journal of Immunology.

GA2LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients

J. Bousquet, T. Zuberbier, C. Bachert, 2009, Allergy.

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

A. Sheikh, R. Van Ree, R. Gerth van Wijk, 2018, Allergy.

Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.

S. Durham, M. Shamji, 2017, The Journal of allergy and clinical immunology.

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.

J. Bousquet, G. Canonica, P. Demoly, 2014, Allergy.

Randomised controlled trial of single, subacromial injection of methylprednisolone in patients with persistent, post-traumatic impingment of the shoulder

S. Durham, J. McInerney, J. Dias, 2003, Emergency medicine journal : EMJ.

T-Cells in the Pathogenesis of Asthma and Allergic Diseases

S. Durham, M. Humbert, 1998 .

Local Somatic Hypermutation and Class Switch Recombination in the Nasal Mucosa of Allergic Rhinitis Patients

S. Durham, Heather Coker, H. Gould, 2003, The Journal of Immunology.

Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.

Stephen R Durham, S. Durham, B. O'connor, 2007, The Journal of allergy and clinical immunology.

Germinal-centre reactions in allergic inflammation.

S. Durham, C. Corrigan, H. Gould, 2006, Trends in immunology.

Allergen Drives Class Switching to IgE in the Nasal Mucosa in Allergic Rhinitis1

S. Durham, Heather Coker, H. Gould, 2005, The Journal of Immunology.

Localization and up‐regulation of Mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis

Dechun Li, S. Durham, N. Caplen, 1997, The Journal of pathology.

Allergen-specific IgG+ memory B cells are temporally linked to IgE memory responses.

C. Lundegaard, S. Durham, Bjoern Peters, 2019, The Journal of allergy and clinical immunology.

ABC of allergies

S. Durham, Stephen R. Durham, 1998 .

MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation

F. Rodenas, G. Joos, R. Bourret, 2015, Allergy.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

A. Sheikh, O. Mayora, T. To, 2019, Clinical and Translational Allergy.

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

A. Sheikh, O. Mayora, T. To, 2019, The Journal of allergy and clinical immunology.

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Todor A Popov, D. Postma, A. Sheikh, 2016, Clinical and Translational Allergy.

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies

A. Sheikh, R. Van Ree, J. Bousquet, 2016, Clinical and Translational Allergy.

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2016, Clinical and Translational Allergy.

Clinical relevance is associated with allergen-specific wheal size in skin prick testing

J. Bousquet, T. Zuberbier, C. Bachert, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Sublingual immunotherapy for allergic rhinitis (Review)

S. Durham, M. Calderón, S. Radulovic, 2010 .

Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009

S. Vieths, J. Bousquet, T. Zuberbier, 2009, Allergy.

Sub-Lingual Immunotherapy

J. Bousquet, T. Zuberbier, C. Baena-Cagnani, 2009, The World Allergy Organization journal.

BSACI guidelines for the management of allergic and non‐allergic rhinitis

D. Ryan, P. Cullinan, P. Howarth, 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Clinical efficacy and immune regulation with peanut oral immunotherapy.

S. Durham, A. Burks, M. Kulis, 2009, The Journal of allergy and clinical immunology.

Allergen immunotherapy: therapeutic vaccines for allergic diseases

Giorgio Walter Canonica, D. Kraft, Martin D. Chapman, 1998 .

Prevalence of pollen-related Oral Allergy Syndrome (OAS) in a UK population

S. Durham, I. Small, I. Skypala, 2010 .

Prevalence and rate of diagnosis of allergic rhinitis in Europe

S. Durham, V. Bauchau, 2004, European Respiratory Journal.

Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF-β Expression1

S. Durham, S. Walker, M. Jacobson, 2007, The Journal of Immunology.

High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma.

S. Durham, M. Humbert, R. Pfister, 1996, American journal of respiratory and critical care medicine.

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy

S. Durham, M. Shamji, Max Kirtland, 2020, Frontiers in Immunology.

New approaches to allergen immunotherapy.

S. Durham, Natasha C. Gunawardana, 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

P. Gergen, W. Busse, G. O'Connor, 2020, Journal of Allergy and Clinical Immunology.

Nasal Allergen Challenge and Environmental Exposure Chamber Challenge: A Randomized Trial Comparing Clinical and Biological Responses to Cat Allergen.

Matthew C. Altman, A. Togias, S. Durham, 2020, The Journal of allergy and clinical immunology.

IL-25/IL-33–responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa

S. Durham, V. Lund, C. Hopkins, 2016, The Journal of allergy and clinical immunology.

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

S. Durham, N. Caplen, D. Porteous, 1995, Nature Medicine.

Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma.

S. Durham, M. Humbert, R. Pfister, 1997, The Journal of allergy and clinical immunology.

EAACI Position paper on the standardization of nasal allergen challenges

S. Durham, J. Mullol, B. Samoliński, 2018, Allergy.

Local nasal immunotherapy for allergic rhinitis: A systematic review and meta‐analysis

G. Canonica, S. Durham, P. Tantilipikorn, 2022, International forum of allergy & rhinology.

Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis

A. Sheikh, S. Durham, D. Larenas-Linnemann, 2017, Allergy.

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial

A. Togias, S. Durham, M. Calderón, 2017, JAMA.

Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language.

J. Bousquet, C. Baena-Cagnani, G. Canonica, 2013, The Journal of allergy and clinical immunology.

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

S. Durham, Stephen R. Durham, Martin Penagos, 2016, The Journal of allergy and clinical immunology.

Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens.

S. Durham, M. Shamji, J. Layhadi, 2021, The journal of allergy and clinical immunology. In practice.

The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines.

R. Van Ree, S. Vieths, S. Durham, 2008, The Journal of allergy and clinical immunology.

Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper

B. Lambrecht, P. Howarth, H. Schünemann, 2008, Allergy.

Allergen immunotherapy for allergic rhinitis.

S. Durham, K. Petalas, S. R. Durham, 2013, Rhinology.

Limited effect of intramuscular epinephrine on cardiovascular parameters during peanut-induced anaphylaxis: An observational cohort study

S. Durham, P. Turner, R. Boyle, 2020, The journal of allergy and clinical immunology. In practice.

Assessment by Nasal Biopsy of Long-Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis:

S. Durham, V. Lund, K. Nolop, 1998 .

Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma

S. Durham, Shih-Ying Wu, L. Ohm-Laursen, 2016, European Respiratory Journal.

Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

S. Durham, G. Yancopoulos, N. Stahl, 2021, American journal of respiratory and critical care medicine.

Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop.

P. Gergen, M. Desai, T. Casale, 2019, The Journal of allergy and clinical immunology.

Sublingual immunotherapy for allergic rhinitis

S. Durham, M. Calderón, S. Radulovic, 2010 .

Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation.

S. Durham, S. Lehmann, C. Schmidt‐Weber, 2013, The Journal of allergy and clinical immunology.

Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper

S. Vieths, J. Bousquet, R. Gerth van Wijk, 2020, Allergy.

The CONSORT statement checklist in allergen‐specific immunotherapy: a GA2LEN paper

H. Schünemann, J. Bousquet, T. Zuberbier, 2009, Allergy.

Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

S. Durham, A. Kay, Q. Hamid, 1994, Immunology.

Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy

S. Durham, K. Nadeau, G. Marone, 2021 .

Visual analogue scale

S. Durham, S. Till, A. Douiri, 2016 .

Conceptions of Long-Term Data Among Marine Conservation Biologists and What Conservation Paleobiologists Need to Know

S. Durham, G. Dietl, Jansen A. Smith, 2018 .

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article.

H. Schünemann, J. Bousquet, T. Zuberbier, 2011, The Journal of allergy and clinical immunology.

Cochrane review: Allergen injection immunotherapy for seasonal allergic rhinitis

A. Sheikh, S. Durham, M. Calderón, 2010 .

Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression.

S. Durham, A. Kay, Q. Hamid, 1993, The American review of respiratory disease.

Leukocyte Activation Following lgE Dependent Mechanisms In Bronchial Asthma

S. Durham, 1989, Clinical reviews in allergy.

Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A?

S. Durham, C. Pilette, Y. Sibille, 2012, Proceedings of the American Thoracic Society.

Objective monitoring of nasal airway inflammation in rhinitis.

P. Howarth, S. Durham, E. Meltzer, 2005, The Journal of allergy and clinical immunology.

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis

S. Durham, A. Eifan, G. Scadding, 2018, Current Treatment Options in Allergy.

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses.

S. Durham, S. Till, M. Shamji, 2012, The Journal of allergy and clinical immunology.

GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe

J. Bousquet, T. Zuberbier, C. Bachert, 2009, Allergy.

Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response.

S. Durham, M. Calderón, L. Turka, 2015, The Journal of allergy and clinical immunology.

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

P Demoly, P. Demoly, S. Durham, 2017, Allergy.

EUFOREA treatment algorithm for allergic rhinitis.

C. Bachert, G. Canonica, S. Durham, 2020, Rhinology.

Duration of allergen immunotherapy for inhalant allergy.

S. Durham, M. Penagos, 2019, Current opinion in allergy and clinical immunology.

Treatment of seasonal allergic rhinitis

S. Durham, 2003, BMJ : British Medical Journal.

Occupational asthma due to styrene.

S. Durham, S. Durham, J. Hopkirk, 1991, Thorax.

Late asthmatic reactions and changes in histamine responsiveness provoked by occupational agents.

S. Durham, A. N. Newman Taylor, B. Graneek, 1987, Bulletin europeen de physiopathologie respiratoire.

Pharmacologic and anti‐IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)

R. Dubakiene, Todor A Popov, B. Yawn, 2006, Allergy.

Expression of IL-4, Cϵ RNA, and Iϵ RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids

S. Durham, E. Minshall, Q. Hamid, 1998 .

Shell repair as a reliable indicator of bivalve predation by shell-wedging gastropods in the fossil record

S. Durham, G. Dietl, P. Kelley, 2010 .

Increasing the salience of marine live–dead data in the Anthropocene

S. Durham, G. Dietl, Jansen A. Smith, 2020, Paleobiology.

How Reaction Severity Is Affected By Cofactors And Repeat Challenges: A Prospective Study Of Peanut Allergic Adults

J. Wason, C. Mills, S. Durham, 2020 .

Discounting the Past: The Undervaluing of Paleontological Data in Conservation Science

S. Durham, G. Dietl, Jansen A. Smith, 2019, Front. Ecol. Evol..

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

H. Schünemann, J. Bousquet, T. Zuberbier, 2019, Journal of thoracic disease.

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Matteo Bonini, Daniel Laune, Boleslaw Samolinski, 2020, Allergy.

Beta₂-agonists for exercise-induced asthma.

H. Schünemann, G. Canonica, S. Durham, 2013, The Cochrane database of systematic reviews.

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2017, Clinical and Translational Allergy.

Basophil Activation Test Using Recombinant Allergens: Highly Specific Diagnostic Method Complementing Routine Tests in Wasp Venom Allergy

S. Durham, J. Ring, U. Darsow, 2014, PloS one.

Allergen immunotherapy for long-term tolerance and prevention.

S. Durham, M. Penagos, 2022, The Journal of allergy and clinical immunology.

Cell-free detection of allergen-IgE cross-linking with immobilized phase CD23: inhibition by blocking antibody responses after immunotherapy.

S. Durham, S. Till, M. Shamji, 2013, The Journal of allergy and clinical immunology.

Allergen immunotherapy: past, present and future

S. Durham, M. Shamji, 2022, Nature Reviews Immunology.

Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE.

S. Durham, E. Varga, W. Aberer, 2013, The Journal of allergy and clinical immunology.

Effects of exercise and sleep deprivation on reaction severity during oral peanut challenge: a randomised controlled trial.

J. Wason, C. Mills, S. Durham, 2022, The journal of allergy and clinical immunology. In practice.

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure

S. Durham, D. Bernstein, H. Nelson, 2014, Allergy.

Prolonged Pre-seasonal Treatment Phase with Sublingual Immunotherapy Increases Clinical Efficacy

S. Durham, M. Calderón, J. Andersen, 2007 .

Pollen season is reflected on symptom load for grass and birch pollen‐induced allergic rhinitis in different geographic areas—An EAACI Task Force Report

M. Sofiev, P. Demoly, R. Gerth van Wijk, 2019, Allergy.

No apparent impact of incremental dosing on eliciting dose at double‐blind, placebo‐controlled peanut challenge

S. Durham, J. Bartra, P. Turner, 2021, Allergy.

Monophosphoryl lipid A: In vitro effects on human T cells proliferation and cytokines production

S. Durham, F. Puggioni, J. Francis, 2003 .

Mechanisms of immunotherapy.

S. Durham, 2008, Drugs of today.

Blocking Antibodies: Relationship between IgG4-associated Inhibitory Activity and Clinical Response to Grass-Pollen Immunotherapy

S. Durham, M. Shamji, I. Kimber, 2010 .

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

A. Sheikh, P. Demoly, S. Durham, 2016, Clinical and Translational Allergy.

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

A. Sheikh, S. Durham, D. Larenas-Linnemann, 2017, Clinical and Translational Allergy.

Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.

T. H. Foo, S. Durham, P. Duncombe, 2003, Rhinology.

Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.

R. Gerth van Wijk, S. Durham, N. Papadopoulos, 2023, Allergy.

IgE-blocking Antibodies may account for a large Proportion of the observed Treatment Effect Induced by Specific Immunotherapy (SIT)

S. Durham, A. Frew, M. Shamji, 2009 .

The effect of immunotherapy on allergen induced late responses.

S. Durham, Q. Hamid, 1997, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M.

SATB1 is repressed in FoxP3+Tregs following Grass Pollen Subcutaneous and Sublingual Immunotherapy and Correlates with Clinical efficacy

S. Durham, M. Shamji, G. Scadding, 2017 .

Rhinitis, sinusitis, and upper airway disease Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis

S. Durham, S. Kleinstein, L. James, 2022 .

Rhinitis, sinusitis, and upper airway disease Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis

S. Durham, S. Kleinstein, L. James, 2022 .

Rhinitis, disease Inﬂuence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis

S. Durham, S. Kleinstein, L. James, 2022 .

Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.

S. Durham, Q. Hamid, M. Jacobson, 1997, European journal of immunology.

Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis.

S. Durham, B. Sutton, Heather Coker, 2005, The Journal of allergy and clinical immunology.

Positive food challenges despite negative specific IgE testing

S. Durham, G. Scadding, I. Skypala, 2011, Clinical and Translational Allergy.

Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immunotherapy

S. Durham, S. Till, L. Wilcock, 2006 .

ARIA update 2008: allergic rhinitis and its effect on asthma

B. Yawn, L. Boulet, J. Bousquet, 2009 .

EAACI MEDIUM-TERM RESEARCH FELLOWSHIP, 2017 Kinetics and Effect of Type 2 Innate Lymphoid Cells on Nasal Tissue of Al lergic Rhinit is after Repetit ive Allergen Challenge and its Relation to TGF -Beta

S. Durham, 2018 .

Immediate-type food allergy to balsam of Peru

S. Durham, G. Scadding, I. Skypala, 2011, Clinical and Translational Allergy.

Effects of Intramuscular Epinephrine on Cardiovascular Parameters during IgE-Mediated Allergic Reactions to Peanut

S. Durham, P. Turner, R. Boyle, 2016 .

EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification

R. G. Das, R. Van Ree, S. Vieths, 2008, Allergy.

The Mismeasure of Behavior: A Natural History Revision of Prey Preference in the Banded Tulip Snail

Christy C. Visaggi, S. Durham, G. Dietl, 2012 .

Dropouts in sublingual allergen immunotherapy trials – a systematic review

S. Durham, E. Ridolo, G. Bisoffi, 2014, Allergy.

Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps

C. Bachert, S. Durham, P. Gevaert, 2013, Allergy.

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial

S. Durham, D. Geddes, Seng H. Cheng, 1999, The Lancet.

The role of IgE, IgG, and IgA in tolerance, sensitization, and targeted treatment of allergic disease

S. Durham, R. Valenta, V. Verhasselt, 2021 .

Development and validation of a structured questionnaire for the diagnosis of oral allergy syndrome in subjects with seasonal allergic rhinitis during the UK birch pollen season

M. Calderon, S. Durham, M. Calderón, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

460 Local control of ε-gene expression in B cells of the nasal mucosa in hay fever patients following allergen-challenge

S. Durham, Q. Hamid, M. Jacobson, 1996 .

The Efficacy Of Single-grass-allergen-immunotherapy-tablet Treatment In Mono- And Multi-sensitized Allergic Rhinitis Patients: Findings From A Post Hoc Analysis

S. Durham, H. Nolte, B. Riis, 2009 .

BSACI guidelines for the management of rhinosinusitis and nasal polyposis

D. Ryan, S. Durham, G. Scadding, 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Biological equilibration of allergen preparations: methodological aspects and reproducibility

G. Nilsson, S. Durham, A. Kay, 1987, Clinical allergy.

Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review

S. Durham, M. Calderón, H. Williams, 2016, Allergy.

Immunotherapy for allergic rhinitis

S. Durham, G. Roberts, S. Walker, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

IL-25/IL-33–responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa

S. Durham, V. Lund, C. Hopkins, 2016, The Journal of allergy and clinical immunology.

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

S. Durham, M. Calderón, L. James, 2008, The Journal of allergy and clinical immunology.

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

S. Durham, H. Behrendt, A. Cavani, 2009, The Journal of clinical investigation.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

Todor A Popov, D. Postma, R. Picard, 2015, Allergy.

Applications and mechanisms of immunotherapy in allergic rhinitis and asthma

S. Durham, M. Shamji, J. Kappen, 2017, Therapeutic advances in respiratory disease.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

O. Mayora, T. To, D. Caillaud, 2019, Clinical and Translational Allergy.

The effect of sleep deprivation and exercise on reaction threshold in peanut-allergic adults: a randomised controlled study

J. Wason, C. Mills, S. Durham, 2020 .

Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.

S. Durham, M. Humbert, A. Kay, 1996, Thorax.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

S. Durham, R. Dahl, A. Kapp, 2006, The Journal of allergy and clinical immunology.

Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy.

S. Durham, L. James, A. Beavil, 2012, The Journal of allergy and clinical immunology.

Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps

C. Bachert, S. Durham, P. Gevaert, 2013, Allergy.

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.

S. Durham, R. Dahl, G. Scadding, 2012, The Journal of allergy and clinical immunology.

Sub-Lingual Immunotherapy

C. Baena-Cagnani, P. Bousquet, J. Brożek, 2009, The World Allergy Organization journal.

GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe

T. Zuberbier, C. Bachert, P. Bousquet, 2009, Allergy.

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

S. Durham, R. Dahl, G. Scadding, 2010, The Journal of allergy and clinical immunology.

Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis

S. Durham, G. Scadding, E. Varga, 1999, Allergy.

EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification

R. G. Das, S. Vieths, K. Fötisch, 2008, Allergy.

Otolaryngology-Head and Neck Surgery

C. Bachert, A. Togias, S. Durham, 2004 .

Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma

S. Durham, R. Dahl, H. Nolte, 2015, Allergy.

Efficacy and safety of the SQ‐standardized grass allergy immunotherapy tablet in mono‐ and polysensitized subjects

S. Durham, M. Blaiss, H. Nelson, 2013, Allergy.

Is pollen‐food syndrome a frequent comorbidity in adults with irritable bowel syndrome?

S. Durham, L. Swan, M. Shamji, 2020, Allergy.

A. Togias, S. Durham, M. Calderón, 2017, JAMA.